The Optimal Management for People with Acute Stroke and Minor Deficits: Intravenous Thrombolysis or Medical Management?

Alan Charles Cameron; Azmil H. Abdul-Rahim

doi:10.1055/a-2077-5642

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2023; 123(07): 666-668
DOI: 10.1055/a-2077-5642

Invited Editorial Focus

The Optimal Management for People with Acute Stroke and Minor Deficits: Intravenous Thrombolysis or Medical Management?

Alan Charles Cameron

¹School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom

,

Azmil H. Abdul-Rahim

²Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

³Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom

References
1 Rivas A, Lauw MN, Schnabel RB, Crowther M, Van Spall HGC. Stroke and thromboembolism in patients with heart failure and sinus rhythm: a matter of risk stratification?. Thromb Haemost 2022; 122 (06) 871-878
2 Lip GYH, Genaidy A, Tran G, Marroquin P, Estes C, Sloop S. Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms. Thromb Haemost 2022; 122 (01) 142-150
3 Chang PY, Wang WT, Wu WL. et al. Oral anticoagulation timing in patients with acute ischemic stroke and atrial fibrillation. Thromb Haemost 2022; 122 (06) 939-950
4 Akyea RK, Georgiopoulos G, Iyen B, Kai J, Qureshi N, Ntaios G. Comparison of risk of serious cardiovascular events after hemorrhagic versus ischemic stroke: a population-based study. Thromb Haemost 2022; 122 (11) 1921-1931
5 Ivany E, Lotto RR, Lip GYH, Lane DA. Managing uncertainty: physicians' decision making for stroke prevention for patients with atrial fibrillation and intracerebral hemorrhage. Thromb Haemost 2022; 122 (09) 1603-1611
6 Lip GYH, Ntaios G. “Novel Clinical Concepts in Thrombosis”: integrated care for stroke management-easy as ABC. Thromb Haemost 2022; 122 (03) 316-319
7 Ferrari J, Reynolds A, Knoflach M, Sykora M. Acute ischemic stroke with mild symptoms-to thrombolyse or not to thrombolyse?. Front Neurol 2021; 12: 760813
8 Emberson J, Lees KR, Lyden P. et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384 (9958): 1929-1935
9 Khatri P, Kleindorfer DO, Devlin T. et al; PRISMS Investigators. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. JAMA 2018; 320 (02) 156-166
10 Romano JG, Gardener H, Campo-Bustillo I. et al; MaRISS Investigators*. Predictors of outcomes in patients with mild ischemic stroke symptoms: MaRISS. Stroke 2021; 52 (06) 1995-2004
11 Khatri P, Conaway MR, Johnston KC. Acute Stroke Accurate Prediction Study (ASAP) Investigators. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 2012; 43 (02) 560-562
12 Tu WJ, Xu Y, Liu Y, Li J, Du J, Zhao J. Intravenous thrombolysis or medical management for minor strokes. Thromb Haemost 2023; 121 (07) 734-743
13 Asdaghi N, Romano JG, Gardener H. et al. Thrombolysis in mild stroke: a comparative analysis of the PRISMS and MaRISS studies. Stroke 2021; 52 (10) e586-e589
14 Berge E, Whiteley W, Audebert H. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 2021; 6 (01) I-LXII
15 Alemseged F, Rocco A, Arba F. et al; Basilar Artery Treatment and Management (BATMAN) Collaboration Investigators. Posterior National Institutes of Health Stroke Scale improves prognostic accuracy in posterior circulation stroke. Stroke 2022; 53 (04) 1247-1255
16 Inoa V, Aron AW, Staff I, Fortunato G, Sansing LH. Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke. Cerebrovasc Dis 2014; 37 (04) 251-255
17 Wang Y, Wang Y, Zhao X. et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369 (01) 11-19
18 Johnston SC, Easton JD, Farrant M. et al; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018; 379 (03) 215-225
19 Dawson J, Merwick Á, Webb A, Dennis M, Ferrari J, Fonseca AC. European Stroke Organisation. European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. Eur Stroke J 2021; 6 (02) CLXXXVII-CXCI
20 ARAMIS trial collaboration. Preliminary results - Antiplatelet Versus Alteplase in Acute Mild Ischemic Stroke (ARAMIS) trial. Oral presentation - Late Breaking Science. 2023 International Stroke Conference (ISC). Accessed April 28, 2023 at: https://isc.hub.heart.org/late-breaking-science/article/22710837/latebreaking-science-bestii-catis2-angelaspect-select-2-aramis-rescue-bt2-and-cmoss